Himanshu Gogoi

About

I am an immunologist specializing in infectious diseases, vaccine development, and host–pathogen interactions. My current research focuses on tuberculosis immunology, mucosal vaccines, nanoparticle-based antigen delivery, and translational immunology, with an emphasis on developing innovative strategies for disease prevention and diagnosis. I have expertise in immunological and molecular biology techniques, including flow cytometry, cell-based assays, and preclinical vaccine evaluation. Through multidisciplinary collaborations, I aim to translate fundamental immunological discoveries into impactful solutions for global infectious disease challenges.

Employment

• Translational Health Science and Technology Institute Ramanujan fellow
  2023 - Present

Education

• Jawaharlal Nehru University Ph.D
  2013 - 2018
• University of Delhi Department of Chemistry M.Sc
  2010 - 2012
• Hansraj College B.Sc
  2007 - 2010

Projects & Funding

Projects & funding information is unavailable.

Publications (25)

• Synthetic Biology for Drug Discovery
  Handbook of Synthetic Biology 2026 DOI: 10.1007/978-981-95-3957-4_28
  +Save
• Acquisition of multiple drug resistance genes by a novel isolate of A. junii from plastic laden landfill soil through horizontal gene transfer
  Gene Reports 2026 DOI: 10.1016/j.genrep.2025.102387
  +Save
• Designing an inclusive online curriculum for reverse vaccinology: a case study from resource-limited setting
  Frontiers in Education 2026 DOI: 10.3389/feduc.2026.1711131
  +Save
• Re-inventing traditional aluminum-based adjuvants: Insight into a century of advancements
  International Reviews of Immunology 2025 DOI: 10.1080/08830185.2024.2404095
  +Save
• Development of Genetically Engineered Vaccine and Post-Exposure Therapy Against Anthrax
  Biotechnology in India - Reworking A Strategy 2024 DOI: 10.1007/978-981-97-0896-3_7
  +Save
• Global Emergence of SARS-CoV2 Infection and Scientific Interventions to Contain its Spread
  Current Protein & Peptide Science 2024 DOI: 10.2174/0113892037274719231212044235
  +Save
• Engineered Nanomaterials for Immunomodulation: A Review
  ACS Applied Bio Materials 2024 DOI: 10.1021/acsabm.3c00940
  +Save
• Bacterial immunotherapy: is it a weapon in our arsenal in the fight against cancer?
  Frontiers in Immunology 2023 DOI: 10.3389/fimmu.2023.1277677
  +Save
• MPYS Modulates Fatty Acid Metabolism and Immune Tolerance at Homeostasis Independent of Type I IFNs
  The Journal of Immunology 2022 DOI: 10.4049/jimmunol.2200158
  +Save
• Unraveling Molecular and Metabolic Gut‐Brain Signalling Disruptions and Potential Therapy in New Bardet‐Biedl Syndrome Mouse
  The FASEB Journal 2022 DOI: 10.1096/fasebj.2022.36.s1.r2708
  +Save